Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Here's Why Merck Stock Vaulted Higher in October


Shares of the pharma giant Merck (NYSE: MRK) rose by 17.2% over the course of October, according to data from S&P Global Market Intelligence. The drugmaker's stock caught fire last month for two interrelated reasons.

Image source: Getty Images.

Since the start of November, Merck's shares have reversed course in a big way. Specifically, the drugmaker's stock is presently down by 7.3% during just the first week of trading this month.

Continue reading


Source Fool.com

Like: 0
MRK
Share

Comments